These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21030394)

  • 1. Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients.
    Hsu J; Fung V; Huang J; Price M; Brand R; Hui R; Fireman B; Dow WH; Bertko J; Newhouse JP
    Health Aff (Millwood); 2010 Dec; 29(12):2335-43. PubMed ID: 21030394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned: who didn't enroll in Medicare drug coverage in 2006, and why?
    Davidoff AJ; Stuart B; Shaffer T; Shoemaker JS; Kim M; Zacker C
    Health Aff (Millwood); 2010 Jun; 29(6):1255-63. PubMed ID: 20466775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unintended effects of the Medicare Part D low income subsidy.
    Decarolis F
    Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy.
    Kautter J; Ingber M; Pope GC; Freeman S
    Med Care; 2012 Dec; 50(12):1102-8. PubMed ID: 22922436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Part D abet advantageous selection in Medicare Advantage?
    Han T; Lavetti K
    J Health Econ; 2017 Dec; 56():368-382. PubMed ID: 29248061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The costs of decedents in the Medicare program: implications for payments to Medicare + Choice plans.
    Buntin MB; Garber AM; McClellan M; Newhouse JP
    Health Serv Res; 2004 Feb; 39(1):111-30. PubMed ID: 14965080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vast majority of Medicare Part D beneficiaries still don't choose the cheapest plans that meet their medication needs.
    Zhou C; Zhang Y
    Health Aff (Millwood); 2012 Oct; 31(10):2259-65. PubMed ID: 23048107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Policy Options To Expand Medicare's Low-Income Provisions To Improve Access And Affordability.
    Schoen C; Buttorff C; Andersen M; Davis K
    Health Aff (Millwood); 2015 Dec; 34(12):2086-94. PubMed ID: 26643629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
    Elliott MN; Landon BE; Zaslavsky AM; Edwards C; Orr N; Beckett MK; Mallett J; Cleary PD
    Health Aff (Millwood); 2016 Mar; 35(3):456-63. PubMed ID: 26953300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor.
    Stuart B; Hendrick FB; Shen X; Dai M; Tom SE; Dougherty JS; Miller LM
    Health Aff (Millwood); 2016 Sep; 35(9):1572-80. PubMed ID: 27605635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
    Atherly A; Dowd B
    Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare's Variation in Out-of-Pocket Costs for Prescriptions: The Irrational Examples of In-Hospital Observation and Home Infusion.
    Wright B; Dusetzina SB; Upchurch G
    J Am Geriatr Soc; 2018 Dec; 66(12):2249-2253. PubMed ID: 30264858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of drug coverage among Medicare beneficiaries with ESRD.
    Howell BL; Powers CA; Weinhandl ED; St Peter WL; Frankenfield DL
    J Am Soc Nephrol; 2012 May; 23(5):959-65. PubMed ID: 22402802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insurers' response to selection risk: Evidence from Medicare enrollment reforms.
    Decarolis F; Guglielmo A
    J Health Econ; 2017 Dec; 56():383-396. PubMed ID: 29248062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.